Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 301–400 of 1,002
Mechanisms of Pancreatic β-Cell Apoptosis in Diabetes and Its Therapies
Johnson, J. D., & Luciani, D. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_19 · Cited by 90
Chu, K. Y., & Leung, P. S. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1590 · Cited by 77
Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation
Sakamaki, J.-I., Fu, A., Reeks, C., Baird, S., Depatie, C., Al Azzabi, M., Bardeesy, N., Gingras, A.-C., Yee, S.-P., & Screaton, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2919 · Cited by 77
Controversies in gestational diabetes
Nolan, C. J. (2010) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.004 · Cited by 96
Luo, X., Li, R., & Yan, L. (2015) · Journal of Diabetes Research · doi:10.1155/2015/512618 · Cited by 93
Impaired β-cell-β-cell coupling mediated by Cx36 gap junctions in prediabetic mice
Carvalho, C. P. F., Oliveira, R. B., Britan, A., Santos-Silva, J. C., Boschero, A. C., Meda, P., & Collares-Buzato, C. B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2011 · Cited by 77
Lipina, C., Stretton, C., Hastings, S., Hundal, J. S., Mackie, K., Irving, A. J., & Hundal, H. S. (2009) · Diabetes · doi:10.2337/db09-0979 · Cited by 89
RetractedLong noncoding RNAs in diseases of aging
Kim, J., Kim, K. M., Noh, J. H., Yoon, J., Abdelmohsen, K., & Gorospe, M. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.06.013 · Cited by 82
“important problems like stroke, atherosclerosis, and heart attack [70].”
BackgroundSun, Y.-N., Zhou, Y., Chen, X., Che, W.-S., & Leung, S.-W. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004619 · Cited by 76
Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.
Ntimbane, T., Comte, B., Mailhot, G., Berthiaume, Y., Poitout, V., Prentki, M., RABASA-LHORET, R. P. R., & Levy, E. H. (2009) · PubMed · Cited by 106
Self-citationJauregui, A. N., Mintz, D. H., Mundel, P. H., & Fornoni, A. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32832f7002 · Cited by 82
Zhao, Z., Zhang, X., Zhao, C., Choi, J., Shi, J., Song, K., Turk, J., & Ma, Z. A. (2010) · Endocrinology · doi:10.1210/en.2010-0016 · Cited by 76
Ishida, E., Kim-Muller, J. Y., & Accili, D. (2017) · Diabetes · doi:10.2337/db16-1213 · Cited by 83
“But, as the disease progresses, hyperglycemia becomes increasingly hard to manage (3), in part because of b-cell failure, which attenuates islet insulin secretion (4).”
BackgroundHerbert, T. P., & Laybutt, D. R. (2016) · Diabetes · doi:10.2337/db15-1633 · Cited by 77
“This is because of a compensatory increase in insulin secretion maintained through an increase in both b-cell function and mass (23).”
BackgroundNutrient Metabolism, Subcellular Redox State, and Oxidative Stress in Pancreatic Islets and β-Cells
Roma, L. P., & Jonas, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.012 · Cited by 84
Hyperglycemia-induced mitochondrial alterations in liver
Dey, A., & Swaminathan, K. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.06.007 · Cited by 78
Hagman, D. K., Latour, M. G., Chakrabarti, S. K., Fontes, G., Amyot, J., Tremblay, C., Semache, M., Lausier, J. A., Roskens, V., Mirmira, R. G., et al. (2008) · Diabetes · doi:10.2337/db07-1285 · Cited by 75
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.
Christensen, M., Knop, F. K., Holst, J. J., & Vilsbøll, T. (2009) · PubMed · Cited by 84
The Genetic Program of Pancreatic β-Cell Replication In Vivo
Klochendler, A., Caspi, I., Corem, N., Moran, M., Friedlich, O., Elgavish, S., Nevo, Y., Helman, A., Glaser, B., Eden, A., et al. (2016) · Diabetes · doi:10.2337/db16-0003 · Cited by 73
“Reduced b-cell mass is a central feature of type 1 and type 2 diabetes, and strategies to enhance b-cell mass are sought as potential regenerative therapies for diabetes (1,2).”
BackgroundMotterle, A., Gattesco, S., Peyot, M., Esguerra, J. L. S., Gómez-Ruiz, A., Laybutt, D. R., Gilon, P., Burdet, F., Ibberson, M. R., Eliasson, L., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.005 · Cited by 86
“These phenomena trigger alterations in the level of key protein-coding genes and microRNAs [3,6,7], a class of small non-coding RNAs playing central roles in numerous physiological and pathological processes [8].”
BackgroundInfluentialSelf-citationShen, J., Hu, M., Tan, W., Ding, J., Jiang, B., Xu, L., Hamulati, H., He, C., Sun, Y., & Xiao, P. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113690 · Cited by 79
Mitochondrial dynamics and morphology in beta-cells
Stiles, L., & Shirihai, O. S. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.004 · Cited by 74
The role of mTOR in the adaptation and failure of β‐cells in type 2 diabetes
Leibowitz, G., Cerasi, E., & Ketzinel‐Gilad, M. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00952.x · Cited by 74
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 73
“Thus, the key role of IR in the onset of this condition is evident and the lack of compensation of the beta-cells of IR occurs in the pathogenesis of T2DM [38].”
BackgroundRole of Wnt signaling pathways in type 2 diabetes mellitus
Chen, J., Ning, C., Mu, J., Li, D., Ma, Y., & Meng, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04086-5 · Cited by 80
Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells
Xiong, X., Wang, G., Tao, R., Wu, P., Kono, T., Li, K., Ding, W., Tong, X., Tersey, S. A., Harris, R. A., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3778-2 · Cited by 80
“The pathogenesis of type 2 diabetes is multifactorial, but impaired insulin secretion from pancreatic beta cells is one of the critical factors [1].”
Zhao, R., Tang, D., Yi, S., Li, W., Wu, C., Lu, Y., Hou, X., Song, J., Lin, P., Chen, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085770 · Cited by 77
Torres-Rovira, L., Astiz, S., Caro‐Vadillo, A., López-Bote, C. J., Óvilo, C., Pallarés, P., Perez-Solana, M., Sánchez, R. S., & Gonzalez‐Bulnes, A. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/510149 · Cited by 88
Westwell-Roper, C. Y., Nąckiewicz, D., Dan, M., & Ehses, J. A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.4 · Cited by 75
Cheng, Q., Law, P. K., de Gasparo, M., & Leung, P. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142703 · Cited by 73
Antkowiak, P. F., Tersey, S. A., Carter, J. D., Vandsburger, M. H., Nadler, J. L., Epstein, F. H., & Mirmira, R. G. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90336.2008 · Cited by 71
Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus
Sommese, L., Zullo, A., Mancini, F. P., Fabbricini, R., Soricelli, A., & Napoli, C. (2017) · Epigenetics · doi:10.1080/15592294.2016.1278097 · Cited by 80
“b-cells to produce more insulin until a progressive b-cell failure takes place and hyperglycemia gets markedly worse.(4) Inflammation, sustained by the innate immune response, has been”
BackgroundThe Role of the Islet Niche on Beta Cell Structure and Function
Lammert, E., & Thorn, P. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.032 · Cited by 79
Misfolded Proinsulin Affects Bystander Proinsulin in Neonatal Diabetes
Hodish, I., Liu, M. R., Rajpal, G., Larkin, D. D., Holz, R. W., Adams, A. M., Liu, L., & Arvan, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038042 · Cited by 84
Mitochondria as target of endocrine-disrupting chemicals: implications for type 2 diabetes
Marroquí, L., Tudurí, E., Alonso‐Magdalena, P., Quesada, I., Nadal, Á., & dos Santos, R. S. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0362 · Cited by 77
Lin, Y., & Sun, Z. (2012) · Endocrinology · doi:10.1210/en.2012-1091 · Cited by 71
Umpierrez, G. E., Gonzalez, A., Umpierrez, D., & Pimentel, D. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180a6efe3 · Cited by 81
Meng, Z.-X., Nie, J., Ling, J.-J., Sun, J.-X., Zhu, Y.-X., Gao, L., Lv, J., Zhu, D.-Y., Sun, Y.-J., & Han, X. (2008) · Diabetologia · doi:10.1007/s00125-008-1174-x · Cited by 72
Kong, F., Wu, J., Sun, S., & Zhou, J. (2017) · Scientific Reports · doi:10.1038/srep44746 · Cited by 77
Minireview: Intraislet Regulation of Insulin Secretion in Humans
Rutter, G. A., & Hodson, D. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1278 · Cited by 77
Normal and defective pathways in biogenesis and maintenance of the insulin storage pool
Liu, M. R., Huang, Y., Xu, X., Li, X., Alam, M., Arunagiri, A., Haataja, L., Ding, L., Wang, S., Itkin‐Ansari, P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142240 · Cited by 67
Lee, K., Chan, J. Y., Liang, C., Ip, C. K., Shi, Y., Herzog, H., Hughes, W. E., Bensellam, M., Delghingaro‐Augusto, V., Koina, M. E., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05669-7 · Cited by 70
Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells
Mukai, E., Fujimoto, S., & Inagaki, N. (2022) · Biomolecules · doi:10.3390/biom12091228 · Cited by 89
Role and therapeutic potential of microRNAs in diabetes
Kolfschoten, I., Roggli, E., Nesca, V., & Regazzi, R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01118.x · Cited by 79
Zapała, B., Kaczyński, Ł., Kieć‐Wilk, B., Staszel, T., Knapp, A., Thoresen, G. H., Wybrańska, I., & Dembinska-Kiec, A. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70337-6 · Cited by 75
Andreassen, K. V., Feigh, M., Hjuler, S. T., Gydesen, S., Henriksen, J. E., Beck-Nielsen, H., Christiansen, C., Karsdal, M. A., & Henriksen, K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00121.2014 · Cited by 70
MitoNEET-Parkin Effects in Pancreatic α- and β-Cells, Cellular Survival, and Intrainsular Cross Talk
Kusminski, C. M., Chen, S., Ye, R., Sun, K., Wang, Q. A., Spurgin, S. B., Sanders, P. E., Brozinick, J. T., Geldenhuys, W. J., Li, W.-H., et al. (2016) · Diabetes · doi:10.2337/db15-1323 · Cited by 69
“The precise mechanisms that impede mitochondrial function and the key pathways that activate b-cell failure and loss of b-cell mass remain unknown (4).”
BackgroundROS-mediated glucose metabolic reprogram induces insulin resistance in type 2 diabetes
Dong, K., Ni, H., Wu, M., Tang, Z., Halim, M., & Shi, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.087 · Cited by 79
Metabolic Effects of Obesity and Its Interaction with Endocrine Diseases
Clark, M., & Hoenig, M. E. (2016) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.04.004 · Cited by 94
Kono, T., Tong, X., Taleb, S., Bone, R. N., Iida, H., Lee, C., Sohn, P., Gilon, P., Roe, M. W., & Evans‐Molina, C. (2018) · Diabetes · doi:10.2337/db17-1351 · Cited by 79
Puri, S., Akiyama, H., & Hebrok, M. (2013) · Genes & Development · doi:10.1101/gad.227785.113 · Cited by 80
“Either as a result of an autoimmune assault or in combination with peripheral insulin resistance, it is now clear that defects in b-cell function are an integral part of diabetes mellitus (Kahn 2003; Prentki and Nolan 2006).”
Backgroundβ‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
β-Cell Insulin Secretion Requires the Ubiquitin Ligase COP1
Suriben, R., Kaihara, K. A., Paolino, M., Reichelt, M., Kummerfeld, S., Modrusan, Z. D., Dugger, D. L., Newton, K., Sagolla, M. S., Webster, J. D., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.076 · Cited by 85
“While b cells activate a number of mechanisms to increase insulin secretion in response to elevated glucose (Prentki and Nolan, 2006), sustained hyperglycemia or hyperkalemia elicits a dose-dependent decrement in b-cell insulin secretion (Eizirik et al.”
12-Lipoxygenase Promotes Obesity-Induced Oxidative Stress in Pancreatic Islets
Tersey, S. A., Maier, B., Nishiki, Y., Maganti, A. V., Nadler, J. L., & Mirmira, R. G. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00157-14 · Cited by 69
Physiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
Marrif, H. I., & Alsunousi, S. I. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00083 · Cited by 87
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ Damage
Elbatreek, M. H., Pachado, M. P., Cuadrado, A., Jandeleit-Dahm, K. A. M., & Schmidt, H. H. H. W. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.006 · Cited by 77
Insulin Secretion Is Increased in Pancreatic Islets of Neuropeptide Y-Deficient Mice
Imai, Y., Patel, H. R., Hawkins, E. J., Doliba, N. M., Matschinsky, F. M., & Ahima, R. S. (2007) · Endocrinology · doi:10.1210/en.2007-0404 · Cited by 68
Imai, J., & Katagiri, H. (2021) · International Immunology · doi:10.1093/intimm/dxab023 · Cited by 80
Pax4 acts as a key player in pancreas development and plasticity.
Napolitano, T., Avolio, F., Courtney, M., Vieira, A., Druelle, N., Ben-Othman, N., Hadzic, B., Navarro, S., & Collombat, P. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.013 · Cited by 68
Shaked, M., Ketzinel‐Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028804 · Cited by 77
HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
Waldman, B., Jenkins, A. J., Davis, T. M. E., Taskinen, M., Scott, R. S., O'Connell, R. L., Gebski, V., Ng, M., & KEECH, A. C. (2014) · Diabetes Care · doi:10.2337/dc13-2738 · Cited by 70
Glucolipotoxicity of the pancreatic β-cell: myth or reality?
Poitout, V. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360901 · Cited by 68
Kayali, A. G., Flores, L. E., Lopez, A. D., Kutlu, B., Baetge, E. E., Kitamura, R., Hao, E., Beattie, G. M., & Hayek, A. (2007) · Diabetes · doi:10.2337/db06-1545 · Cited by 75
Roat, R., Rao, V., Doliba, N. M., Matschinsky, F. M., Tobias, J. W., Garcia, E., Ahima, R. S., & Imai, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086815 · Cited by 79
“(i) BL6J mice partially compensate for insulin resistance on high fat diet We determined whether BL6J developed a progressive decline in glucose homeostasis that is commonly seen in human T2D [3].”
BackgroundKebede, M. A., Ferdaoussi, M., Mancini, A. D., Alquier, T., Kulkarni, R., WALKER, M. D., & Poitout, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114350109 · Cited by 77
Restoring a functional β‐cell mass in diabetes
Pipeleers, D., Chintinne, M., Denys, B., Martens, G., Keymeulen, B., & Gorus, F. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00941.x · Cited by 66
Albersen, M., Lin, G., Fandel, T. M., Zhang, H., Qiu, X., Lin, C., & Lue, T. F. (2011) · Urology · doi:10.1016/j.urology.2011.03.024 · Cited by 66
Ding, Y., Zhang, Z., Dai, X., Jiang, Y., Bao, L., Li, Y., & Li, Y. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-51 · Cited by 73
Diabetes: Mechanism, Pathophysiology and Management-A Review
Siddiqui, A. A., Siddiqui, S. A., Ahmad, S., Siddiqui, S., Ahsan, I., & Sahu, K. (2013) · International Journal of Drug Development and Research · Cited by 113
Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2
Grindel, A., Guggenberger, B., Eichberger, L., Pöppelmeyer, C., Gschaider, M., Tosevska, A., Mare, G., Briskey, D. R., Brath, H., & Wagner, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162082 · Cited by 72
“Untreated, the underlying hyperglycemia leads to a ß-cell failure and an indispensable need for exogenous insulin supply [4, 5].”
BackgroundAmo-Shiinoki, K., Tanabe, K., Hoshii, Y., Matsui, H., Harano, R., Fukuda, T., Takeuchi, T., Bouchi, R., Takagi, T., Hatanaka, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143791 · Cited by 74
Xie, J., & Herbert, T. P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0874-4 · Cited by 72
Schrimpe‐Rutledge, A. C., Fontès, G., Gritsenko, M. A., Norbeck, A. D., Anderson, D. J., Waters, K. M., Adkins, J., Smith, R. D., Poitout, V., & Metz, T. (2012) · Journal of Proteome Research · doi:10.1021/pr3002996 · Cited by 74
Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update)
Gallwitz, B. (2007) · Drugs of Today · doi:10.1358/dot.2007.43.11.1157620 · Cited by 66
Kyriazis, G. A., Smith, K. R., Tyrberg, B., Hussain, T., & Pratley, R. E. (2014) · Endocrinology · doi:10.1210/en.2013-2015 · Cited by 67
Dadi, P. K., Vierra, N. C., Ustione, A., Piston, D. W., Colbran, R. J., & Jacobson, D. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562587 · Cited by 66
“Therefore, changes in CaMKII signaling may contribute to aberrant -cell function following HFD feeding, during the progression of diabetes (52, 53).”
BackgroundBrun, T., He, K. H. H., Lupi, R., Boehm, B. O., Wojtusciszyn, A., Sauter, N. S., Donath, M. Y., Marchetti, P., Maedler, K., & Gauthier, B. R. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm325 · Cited by 68
Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health
Tong, X., Dai, C., Walker, J. T., Nair, G. G., Kennedy, A. J., Carr, R. M., Hebrok, M., Powers, A. C., & Stein, R. W. (2019) · Diabetes · doi:10.2337/db19-0281 · Cited by 72
“A number of modifiable factors have been linked to islet b-cell deterioration in T2D including chronic hyperglycemia and elevated levels of free fatty acids like palmitate (29).”
BackgroundReed, S., Taka, E., Darling‐Reed, S., & Soliman, K. F. A. (2025) · Cells · doi:10.3390/cells14141064 · Cited by 82
“In this condition, the pancreas cannot produce enough insulin to control the glucose input, leading to hyperglycemia [26].”
Endoplasmic Reticulum Stress in the β-Cell Pathogenesis of Type 2 Diabetes
Back, S. H., Kang, S.-W., Han, J., & Chung, H.-T. (2012) · Experimental Diabetes Research · doi:10.1155/2012/618396 · Cited by 65
Vettor, R., Granzotto, M., Stefani, D. D., Trevellin, E., Rossato, M., Farina, M. G., Milan, G., Pilon, C., Nigro, A., Federspil, G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2680 · Cited by 75
Dokmanovic-Chouinard, M., Chung, W. K., Chèvre, J.-C., Watson, E., Yonan, J., Wiegand, B., Bromberg, Y., Wakae, N., Wright, C. V. E., Overton, J. D., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000137 · Cited by 76
Pournourmohammadi, S., Grimaldi, M., Stridh, M. H., Lavallard, V., Waagepetersen, H. S., Wollheim, C. B., & Maechler, P. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.01.012 · Cited by 72
Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
Hernández, M. G., García-Aguilar, A., Burillo, J., Gómez, R., Manca, M. A., Novials, A., Alcarraz‐Vizán, G., Guillén, C., & Benito, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0533-x · Cited by 70
Gleason, C. E., Ning, Y., Cominski, T. P., Gupta, R. K., Kaestner, K. H., Pintar, J. E., & Birnbaum, M. J. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0167 · Cited by 63
Epigenetic Changes in Gestational Diabetes Mellitus
Dłuski, D. F., Wolińska, E., & Skrzypczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147649 · Cited by 79
“Mostly, impairments at every step of insulin synthesis or secretion have been described; dysfunction of β-cells is activated by hyperglycemia and hyperlipidemia [34].”
BackgroundBeta-cell compensation and gestational diabetes
Usman, T. O., Chhetri, G., Yeh, H., & Dong, H. H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105405 · Cited by 83
“…β -cell compensation is an adaptive mechanism by which β -cells release more insulin in response to insulin resistance or metabolic stress (19, 20). β -cell compensation is orchestrated by β -cell mass expansion, increased insulin synthesis and secretion, enhanced glucose sensing, and…”
BackgroundGeniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway
Yao, D. D., Yang, L., Wang, Y., Liu, C., Wei, Y., Jia, X., Yin, W., & Shu, L. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.107 · Cited by 71
Janikiewicz, J., Hanzelka, K., Dziewulska, A., Koziński, K., Dobrzyń, P., Bernaś, T., & Dobrzyń, A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059980 · Cited by 68
CNC-bZIP Protein Nrf1-Dependent Regulation of Glucose-Stimulated Insulin Secretion
Zheng, H., Fu, J., Xue, P., Zhao, R., Dong, J., Liu, D., Yamamoto, M. P., Tong, Q., Teng, W., Qu, W., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6017 · Cited by 70
“Before the onset of clinical T2D, b-cells compensate for increased insulin resistance in peripheral tissues by hypersecreting insulin (36).”
BackgroundInfluentialRole of Pancreatic Transcription Factors in Maintenance of Mature β-Cell Function
Kaneto, H., & Matsuoka, T. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036281 · Cited by 67
Anti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas
Yin, W., Li, B., Li, X., Yu, F., Cai, Q., Zhang, Z., Cheng, M., & Gao, H. (2015) · Food & Function · doi:10.1039/c5fo00496a · Cited by 67
Peyot, M.-L., Gray, J. P., Lamontagne, J., Smith, P. J. S., Holz, G. G., Madiraju, S. R. M., Prentki, M., & Heart, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006221 · Cited by 64
Self-citationHansen, H. H., Jelsing, J., Hansen, C. F., Hansen, G., Vrang, N., Mark, M., Klein, T., & Mayoux, E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213454 · Cited by 65
“…by continued increased insulin demand, in combination, may lead to disease progression as a consequence of islet b-cell secretory defects, lowered b-cell proliferative rate, and augmented apoptotic b-cell death (Pick et al., 1998; Prentki and Nolan 2006; Topp et al., 2007; Paulsen et al., 2010).”
BackgroundResultGenetic and biochemical pathways of β‐cell failure in type 2 diabetes
Talchai, C., Lin, H. V., Kitamura, T., & Accili, D. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01115.x · Cited by 63
Bellin, M. D., Beilman, G. J., Dunn, T. B., Pruett, T. L., Chinnakotla, S., Wilhelm, J. J., Ngo, A. T., Radosevich, D. M., Freeman, M. L., Schwarzenberg, S. J., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182681182 · Cited by 67
“Intensive insulin therapy and maintenance of goal or near goal HbA1c may be critical to the preservation of islet function, to avoid the effects of glucotoxicity on the remaining beta cell mass.(17,18) It is promising that some diabetic IAT recipients have clinically significant C-peptide production early after transp…”
BackgroundYang, B., Fu, J., Zheng, H., Xue, P., Yarborough, K., Woods, C. G., Hou, Y., Zhang, Q., Andersen, M. E., & Pi, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.09.012 · Cited by 67
Role of MicroRNAs in Islet Beta-Cell Compensation and Failure during Diabetes
Plaisance, V., Waeber, G., Regazzi, R., & Abderrahmani, A. (2014) · Journal of Diabetes Research · doi:10.1155/2014/618652 · Cited by 71
Attané, C., Peyot, M., Lussier, R., Poursharifi, P., Zhao, S., Zhang, D., Morin, J., Pineda, M., Wang, S., Dumortier, O., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4105-2 · Cited by 64
Self-citation
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.